-+ 0.00%
-+ 0.00%
-+ 0.00%

Microbix to Present Research on Hepatitis C Test Controls at EMMD 2026

PUBT·11/02/2026 14:31:08
Microbix to Present Research on Hepatitis C Test Controls at EMMD 2026
  • Microbix Biosystems will present findings on hepatitis C diagnostic test controls at the European Meeting on Molecular Diagnostics, November 4-6, 2026.
  • The poster examines synthetic DNA and RNA controls designed to improve access to reproducible hepatitis C testing.
  • DNA controls are optimized for point-of-need testing; RNA controls target laboratory workflows, addressing differing quality-control needs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbix Biosystems Inc. published the original content used to generate this news brief on November 02, 2026, and is solely responsible for the information contained therein.